Home
Platform
Services
Brands
Locations
Careers
News
Library
Responsibility
Contact Us
Platform
Our Platform
Our Competitive Edge
Services
Preclinical Development
Clinical Development
Regulatory Affairs & Consulting
Data Sciences
Molecular Laboratory R&D Services
Microbiology and Diagnostics R&D Services
Brands
Clinglobal
About us
Our Services
Our Team
Clinvet
About us
Our Services
Our Team
Clindata
About us
Our Services
Our Team
Clinomics
About us
Our Services
Our Team
Clinaxel
Rtilab
Locations
Careers
News
Social Media
Library
Research Models
Publications
Responsibility
Our Purpose
Our Values
Corporate Responsibility
Compliance
Contact us
Safety evaluation of a novel topical combination of esafoxolaner, eprinomectin and praziquantel, in reproducing female cats
Home
Safety evaluation of a novel topical combination of esafoxolaner, eprinomectin and praziquantel, in reproducing female cats
digitalplatforms
April 24, 2025
0 Comments
File Type:
pdf
File Size:
143 KB
Categories:
Publications
Post navigation
Previous
Repellency, prevention of attachment and acaricidal efficacy of a new combination of fipronil and permethrin against the main vector of canine babesiosis in Europe, Dermacentor reticulatus ticks
Next
Serum Cannabinoid 24 h and 1 week Steady State PK Assessment in Cats Using a CBD-CBDA Rich Hemp Paste
